Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The SISR Randomized Trial von Holmes, David R, Teirstein, Paul, Satler, Lowell, Sketch, Michael, O’Malley, James, Popma, Jeffery J, Kuntz, Richard E, Fitzgerald, Peter J, Wang, Hong, Caramanica, Eileen, Cohen, Sidney A, SISR Investigators, for the

Volltext

Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial von Alli, Oluseun O., MD, Teirstein, Paul S., MD, Satler, Lowell, MD, Sketch, Michael H., MD, Popma, Jeffery J., MD, Mauri, Laura, MD, MSc, Wang, Hong (Patrick), MD, MPH, Schleckser, Patricia A., BS, Cohen, Sidney A., MD, PhD, Holmes, David R., MD

Volltext

3-Year Follow-Up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) Trial von Holmes, David R., MD, Teirstein, Paul S., MD, Satler, Lowell, MD, Sketch, Michael H., MD, Popma, Jeffery J., MD, Mauri, Laura, MD, MSc, Wang, Hong (Patrick), MD, MPH, Schleckser, Patricia A., BS, Cohen, Sidney A., MD, PhD

Volltext